ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,068Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 769

$1.03M Total Retail Price of All Prescriptions

Rank: 35 out of 769

484 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$103 was the average price of a prescription from this provider, compared to $121 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 700 649 147 1 1
LOSARTAN POTASSIUM 557 476 122 2 6
FUROSEMIDE 485 424 113 3 2
LISINOPRIL 317 286 68 4 4
SIMVASTATIN 244 206 49 5 5
ATORVASTATIN CALCIUM 231 203 44 6 10
CALCITRIOL 231 226* 58 6 16
DIOVAN 228 211 39 8 19
RENVELA 225 173 50 9 3
CARVEDILOL 204 187 42 10 11
OMEPRAZOLE 183 155 51 11 8
JANUVIA 178 173* 30 12 35
PIOGLITAZONE HCL 161 141 28 R 13 67
CLONIDINE HCL 144 109 24 14 17
SENSIPAR 143 90 26 15 7
CLOPIDOGREL 137 132* 35 16 26
CLINISOL 137 <11 <11 16 50
METOPROLOL TARTRATE 133 121 31 18 9
PANTOPRAZOLE SODIUM 132 127* 26 19 31
BENAZEPRIL HCL 128 103 27 20 28
TRAMADOL HCL 123 108 60 21 44
HYDROCHLOROTHIAZIDE 123 108 39 21 27
CALCIUM ACETATE 115 88 32 23 14
ATENOLOL 112 94 26 24 23
LEVOTHYROXINE SODIUM 102 97* 21 25 13
SERTRALINE HCL 95 90* 18 26 73
ALLOPURINOL 92 87* 18 27 12
TAMSULOSIN HCL 90 85* 19 28 25
PRAVASTATIN SODIUM 88 75 19 29 39
ALENDRONATE SODIUM 87 74 19 30 42
RISPERIDONE 81 76* 15 A 31 126
TRIAMCINOLONE ACETONIDE 79 74* 16 32 84
HYDROCODONE-ACETAMINOPHEN 78 56 25 S3 33 15
LACTULOSE 75 70* 22 34 112
GABAPENTIN 75 70* 26 34 21
MINOXIDIL 74 38 13 36 59
FAMOTIDINE* 71 66* 17 37 38
POTASSIUM CHLORIDE 68 68 13 38 37
ADVAIR DISKUS 67 62* 18 39 93
METFORMIN HCL 64 50 14 40 22
GEMFIBROZIL 63 <11 <11 41 123
DONEPEZIL HCL 56 <11 <11 42 49
ENALAPRIL MALEATE 55 42 17 43 66
ALBUTEROL SULFATE 51 <11 <11 44 133
CIPROFLOXACIN HCL 51 46* 31 44 92
MEGESTROL ACETATE 51 46* 16 R 44 71
PROAIR HFA 50 38 16 47 82
FLUTICASONE PROPIONATE 50 36 13 47 83
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.